Viraday is a combined agent that includes efavirenz, emtricitabine, and tenofovir and is used to treat HIV. The combination of substances included in the composition of a drug significantly simplifies the schedule of using medications and helps patients to strictly observe the time of admission. In addition, the appointment of combined funds prevents the development of resistance (resistance) of the virus to certain substances.
Ledifos Tablets has undergone numerous clinical trials and is approved for the treatment of patients with 1 and 4 genotypes of the virus. The research results showed that the chances of recovery start from 95% and reach 100% of the value with the correct course of therapy.
The drug does not require combinations with other drugs, and, due to low toxicity, has a minimum of side effects, the most difficult of which will be a feeling of fatigue, and, perhaps, mild headache. No more ribavirin and interferon - this poison can be safely thrown into the trash.